Oregovomab is a highly specialized murine monoclonal antibody target the tumor-associated antigen CA125 (MUC16), induction of robust anti-idiotypic antibody responses and T-cell mediated anti-tumor immunity by forming immune complexes across various preclinical experimental models.
CAS Number:
[213327-37-8]
Target:
Mucin
* VAT and and shipping costs not included. Errors and price changes excepted